<DOC>
	<DOCNO>NCT02323776</DOCNO>
	<brief_summary>The purpose study identify feature cumulative dose-volume histogram ( DVH ) patient treat trimodality therapy oesophageal cancer correlate postoperative complication .</brief_summary>
	<brief_title>Defining Radiotherapy Dose Volume Parameters Affecting Postoperative Complications Esophageal Cancer Patients</brief_title>
	<detailed_description>Intention treat analysis patient initially assign treated trimodality protocol : neoadjuvant chemoradiotherapy follow surgery . The investigator retrospectively evaluate several parameter treatment planning patient treat preoperative regimen ( CROSS regimen 41,4 Gy 23 fraction 50 , 4 Gy 28 fraction ) : - PTV volume1 - MLD , V30 , V20 , V15 , V10 , VS5 ( Volume lung less dan 5 Gy ) 2 ( lung toxicity ) - MHD , V20 , V30 , V403 ( heart toxicity ) - Mean stomach dose , V50 stomach - Mitochondrial DNA available per patient Pre-existing cardiac , pulmonary comorbidity , smoke behavior , BMI , type surgery chemotherapy ( especially taxanes ) score take account multivariate analysis . The investigator collect data correlate data presence postoperative complication , time onset complication duration hospitalization . These latter data already score prospective manner Atrium Medical Center Heerlen .</detailed_description>
	<mesh_term>Esophageal Neoplasms</mesh_term>
	<mesh_term>Postoperative Complications</mesh_term>
	<criteria>Oesophageal cancer patient initially treat preoperative dose radiation combination chemotherapy subsequently undergone surgical resection Patients treat definitive chemoradiation palliative radiotherapy</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2016</verification_date>
</DOC>